Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-17-049764

See Remarks returned 300,000 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
KINGSLEY ALFRED D See Remarks 2017-08-17 Returned to the company −300,000 $2.81 $843,000 5,481,555 D: show line 1 in the form
Loading xslF345X03/doc4.xml…